Home > Healthcare > Biotechnology > Biotechnology R&D > Genetic Testing Market
Genetic Testing Market Share
- Report ID: GMI2490
- Published Date: Mar 2023
- Report Format: PDF
Genetic Testing Market Share
Some of the major players in the genetic testing market include
- Siemens Healthineers AG
- Roche Diagnostics
- Quest Diagnostics
- Qiagen
- Natera, Inc.
- Luminex Corporation
- Invitae Corporation
- Illumina, Inc.
- Eurofins Scientific
- deCODE Genetics (Amgen)
- Cepheid (Danaher Corporation)
- Blueprint Genetics
- Ambry Genetics (Konica MinoltabioMérieux SA)
- Abbott Laboratories
- 23andMe, Inc.
Product range and geographical expansions are among the key initiatives being undertaken by these companies to strengthen their market presence.
Frequently Asked Questions (FAQ) :
Global market for genetic testing was valued at over USD 18 billion in 2022 and is expected to register more than 8.5% CAGR through 2023-2032, due to growing awareness of hereditary mutations and cancer risks.
Cancer diagnosis segment is set to depict over 9% CAGR through 2023-2032, owing to the rise in alcohol dependence.
North America region accounted for over 53% share of the genetic testing industry in 2022, on account of the high burden of cardiovascular diseases.
Some of the key players in the genetic testing market include Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics, Qiagen, Invitae Corporation, Illumina, Inc., deCODE Genetics (Amgen), Abbott Laboratories, and 23andMe, Inc., among others.
Genetic Testing Market Scope
×
Get a free sample of
Genetic Testing Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below